Child and Adolescent Depression: A Review of Theories, Evaluation Instruments, Prevention Programs, and Treatments

Overview

Journal Front Psychol

Date 2019 Apr 6

PMID 30949092

Citations 60

Authors

Elena Bernaras

Joana Jaureguizar

Maite Garaigordobil

Affiliations

Soon will be listed here.

Abstract

Depression is the principal cause of illness and disability in the world. Studies charting the prevalence of depression among children and adolescents report high percentages of youngsters in both groups with depressive symptoms. This review analyzes the construct and explanatory theories of depression and offers a succinct overview of the main evaluation instruments used to measure this disorder in children and adolescents, as well as the prevention programs developed for the school environment and the different types of clinical treatment provided. The analysis reveals that in mental classifications, the child depression construct is no different from the adult one, and that multiple explanatory theories must be taken into account in order to arrive at a full understanding of depression. Consequently, both treatment and prevention should also be multifactorial in nature. Although universal programs may be more appropriate due to their broad scope of application, the results are inconclusive and fail to demonstrate any solid long-term efficacy. In conclusion, we can state that: (1) There are biological factors (such as tryptophan-a building block for serotonin-depletion, for example) which strongly influence the appearance of depressive disorders; (2) Currently, negative interpersonal relations and relations with one's environment, coupled with social-cultural changes, may explain the increase observed in the prevalence of depression; (3) Many instruments can be used to evaluate depression, but it is necessary to continue to adapt tests for diagnosing the condition at an early age; (4) Prevention programs should be developed for and implemented at an early age; and (5) The majority of treatments are becoming increasingly rigorous and effective. Given that initial manifestations of depression may occur from a very early age, further and more in-depth research is required into the biological, psychological and social factors that, in an interrelated manner, may explain the appearance, development, and treatment of depression.

Citing Articles

Investigating the relationship between inflammatory cytokines and adolescent depression: a comparative analysis.

Liu M, Tang J, Xu G, Chen X, Fang K, He F Front Psychiatry. 2025; 16:1524015.

PMID: 39980978 PMC: 11839723. DOI: 10.3389/fpsyt.2025.1524015.

The Etiopathogenic Mosaic of Suicidal Behaviour.

Temelie-Olinici D, Knieling A, Vata D, Gheuca-Solovastru L, Neamtu M, Mocanu M Behav Sci (Basel). 2025; 15(1).

PMID: 39851890 PMC: 11761583. DOI: 10.3390/bs15010087.

Effects of Ketamine vs. Midazolam in Adolescent Treatment Resistant Depression.

Macejova A, Kovacova V, Tonhajzerova I, Visnovcova Z, Ferencova N, Mlyncekova Z Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770470 PMC: 11728720. DOI: 10.3390/ph17121627.

Psychometric properties of an Arabic translation of the 13-item short mood and feelings questionnaire- parent version (SMFQ-P) to screen for depression in children.

Noureddine A, Malaeb D, Khatib S, Dabbous M, Sakr F, Ali A BMC Psychiatry. 2025; 25(1):2.

PMID: 39748341 PMC: 11697484. DOI: 10.1186/s12888-024-06433-4.

Social support and self-efficacy during early adolescence: Dual impact of protective and promotive links to mental health and wellbeing.

Cherewick M, Lama R, Rai R, Dukpa C, Mukhia D, Giri P PLOS Glob Public Health. 2024; 4(12):e0003904.

PMID: 39739662 PMC: 11687749. DOI: 10.1371/journal.pgph.0003904.

References

Roberts J, Gotlib I, Kassel J . Adult attachment security and symptoms of depression: the mediating roles of dysfunctional attitudes and low self-esteem. J Pers Soc Psychol. 1996; 70(2):310-20. DOI: 10.1037//0022-3514.70.2.310. View

Herane-Vives A, Fischer S, de Angel V, Wise T, Cheung E, Chua K . Elevated fingernail cortisol levels in major depressive episodes. Psychoneuroendocrinology. 2017; 88:17-23. DOI: 10.1016/j.psyneuen.2017.10.026. View

Hilsenroth M, Ackerman S, Blagys M, Baity M, Mooney M . Short-term psychodynamic psychotherapy for depression: an examination of statistical, clinically significant, and technique-specific change. J Nerv Ment Dis. 2003; 191(6):349-57. DOI: 10.1097/01.NMD.0000071582.11781.67. View

Figueras Masip A, Amador Campos J, Olmos J . Psychometric properties of the Reynolds Child Depression Scale in community and clinical samples. Span J Psychol. 2008; 11(2):641-9. View

Thabrew H, Stasiak K, Bavin L, Frampton C, Merry S . Validation of the Mood and Feelings Questionnaire (MFQ) and Short Mood and Feelings Questionnaire (SMFQ) in New Zealand help-seeking adolescents. Int J Methods Psychiatr Res. 2018; 27(3):e1610. PMC: 6877137. DOI: 10.1002/mpr.1610. View

Miller W, Seligman M . Depression and learned helplessness in man. J Abnorm Psychol. 1975; 84(3):228-38. DOI: 10.1037/h0076720. View

Reeves A, Mckee M, Stuckler D . Economic suicides in the Great Recession in Europe and North America. Br J Psychiatry. 2014; 205(3):246-7. DOI: 10.1192/bjp.bp.114.144766. View

Birleson P, Hudson I, Buchanan D, Wolff S . Clinical evaluation of a self-rating scale for depressive disorder in childhood (Depression Self-Rating Scale). J Child Psychol Psychiatry. 1987; 28(1):43-60. DOI: 10.1111/j.1469-7610.1987.tb00651.x. View

Rooney R, Hassan S, Kane R, Roberts C, Nesa M . Reducing depression in 9-10 year old children in low SES schools: a longitudinal universal randomized controlled trial. Behav Res Ther. 2013; 51(12):845-54. DOI: 10.1016/j.brat.2013.09.005. View

10.

Barber B, Stolz H, Olsen J . Parental support, psychological control, and behavioral control: assessing relevance across time, culture, and method. Monogr Soc Res Child Dev. 2005; 70(4):1-137. DOI: 10.1111/j.1540-5834.2005.00365.x. View

11.

Kaufman J, Wymbs N, Montalvo-Ortiz J, Orr C, Albaugh M, Althoff R . Methylation in OTX2 and related genes, maltreatment, and depression in children. Neuropsychopharmacology. 2018; 43(11):2204-2211. PMC: 6135753. DOI: 10.1038/s41386-018-0157-y. View

12.

Jellinek M, Evans N, Knight R . Use of a behavior checklist on a pediatric inpatient unit. J Pediatr. 1979; 94(1):156-8. DOI: 10.1016/s0022-3476(79)80386-8. View

13.

Armsden G, McCauley E, Greenberg M, Burke P, Mitchell J . Parent and peer attachment in early adolescent depression. J Abnorm Child Psychol. 1990; 18(6):683-97. DOI: 10.1007/BF01342754. View

14.

Farrell L, Barrett P . Prevention of Childhood Emotional Disorders: Reducing the Burden of Suffering Associated with Anxiety and Depression. Child Adolesc Ment Health. 2020; 12(2):58-65. DOI: 10.1111/j.1475-3588.2006.00430.x. View

15.

Wagner K, Ambrosini P . Childhood depression: pharmacological therapy/treatment (pharmacotherapy of childhood depression). J Clin Child Psychol. 2001; 30(1):88-97. DOI: 10.1207/S15374424JCCP3001_10. View

16.

Branchi I . The double edged sword of neural plasticity: increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover. Psychoneuroendocrinology. 2010; 36(3):339-51. DOI: 10.1016/j.psyneuen.2010.08.011. View

17.

Cole D, Rehm L . Family interaction patterns and childhood depression. J Abnorm Child Psychol. 1986; 14(2):297-314. DOI: 10.1007/BF00915448. View

18.

Clarke G, Hawkins W, Murphy M, Sheeber L, Lewinsohn P, Seeley J . Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents: a randomized trial of a group cognitive intervention. J Am Acad Child Adolesc Psychiatry. 1995; 34(3):312-21. DOI: 10.1097/00004583-199503000-00016. View

19.

Demir T, Karacetin G, Demir D, Uysal O . Epidemiology of depression in an urban population of Turkish children and adolescents. J Affect Disord. 2011; 134(1-3):168-76. DOI: 10.1016/j.jad.2011.05.041. View

20.

Peiro S, Cervera P, Bernal-Delgado E . [Selective serotonin reuptake inhibitors in childhood depression: a soap opera that reflects serious problems of drug safety]. Gac Sanit. 2005; 19(5):401-6. DOI: 10.1157/13080141. View